Alignment Healthcare Inc. (ALHC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Alignment Healthcare Statistics
Share Statistics
Alignment Healthcare has 191.70M shares outstanding. The number of shares has increased by 1.44% in one year.
Shares Outstanding | 191.70M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.21% |
Owned by Institutions (%) | n/a |
Shares Floating | 92.28M |
Failed to Deliver (FTD) Shares | 1.45K |
FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 9.35M, so 4.88% of the outstanding shares have been sold short.
Short Interest | 9.35M |
Short % of Shares Out | 4.88% |
Short % of Float | 10.15% |
Short Ratio (days to cover) | 3.81 |
Valuation Ratios
The PE ratio is -10.83 and the forward PE ratio is -25.8.
PE Ratio | -10.83 |
Forward PE | -25.8 |
PS Ratio | 0.88 |
Forward PS | 0.7 |
PB Ratio | 10.22 |
P/FCF Ratio | -16.84 |
PEG Ratio | n/a |
Enterprise Valuation
Alignment Healthcare Inc. has an Enterprise Value (EV) of 1.57B.
EV / Earnings | -10.61 |
EV / Sales | 0.86 |
EV / EBITDA | -14.92 |
EV / EBIT | -12.29 |
EV / FCF | -16.51 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 1.09.
Current Ratio | 1.84 |
Quick Ratio | 1.84 |
Debt / Equity | 1.09 |
Total Debt / Capitalization | 52.11 |
Cash Flow / Debt | -0.35 |
Interest Coverage | -6.02 |
Financial Efficiency
Return on equity (ROE) is -0.94% and return on capital (ROIC) is -38.86%.
Return on Equity (ROE) | -0.94% |
Return on Assets (ROA) | -0.25% |
Return on Capital (ROIC) | -38.86% |
Revenue Per Employee | 1.19M |
Profits Per Employee | -96.37K |
Employee Count | 1.54K |
Asset Turnover | 3.08 |
Inventory Turnover | 0 |
Taxes
Income Tax | -22.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 118.5% in the last 52 weeks. The beta is 1.46, so Alignment Healthcare 's price volatility has been higher than the market average.
Beta | 1.46 |
52-Week Price Change | 118.5% |
50-Day Moving Average | 12.22 |
200-Day Moving Average | 9.73 |
Relative Strength Index (RSI) | 81.35 |
Average Volume (20 Days) | 1.96M |
Income Statement
In the last 12 months, Alignment Healthcare had revenue of 1.82B and earned -148.02M in profits. Earnings per share was -0.79.
Revenue | 1.82B |
Gross Profit | 201.03M |
Operating Income | -127.82M |
Net Income | -148.02M |
EBITDA | -105.30M |
EBIT | -127.82M |
Earnings Per Share (EPS) | -0.79 |
Balance Sheet
The company has 202.90M in cash and 170.79M in debt, giving a net cash position of 32.12M.
Cash & Cash Equivalents | 202.90M |
Total Debt | 170.79M |
Net Cash | 32.12M |
Retained Earnings | -880.26M |
Total Assets | 692.29M |
Working Capital | 215.52M |
Cash Flow
In the last 12 months, operating cash flow was -59.19M and capital expenditures -35.99M, giving a free cash flow of -95.18M.
Operating Cash Flow | -59.19M |
Capital Expenditures | -35.99M |
Free Cash Flow | -95.18M |
FCF Per Share | -0.51 |
Margins
Gross margin is 11.02%, with operating and profit margins of -7.01% and -8.12%.
Gross Margin | 11.02% |
Operating Margin | -7.01% |
Pretax Margin | -8.13% |
Profit Margin | -8.12% |
EBITDA Margin | -5.77% |
EBIT Margin | -7.01% |
FCF Margin | -5.22% |
Dividends & Yields
ALHC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -5.11% |
FCF Yield | -3.21% |
Analyst Forecast
The average price target for ALHC is $12, which is -22.4% lower than the current price. The consensus rating is "Buy".
Price Target | $12 |
Price Target Difference | -22.4% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Scores
Altman Z-Score | 4.37 |
Piotroski F-Score | 2 |